SME Times is powered by   
Search News
Just in:   • BRICS playing bigger role in new world economic order  • S. Korea's nominal GDP grows at fastest pace in 47 years in April-June  • South Africa envoy says trade with India to get booster shot at BRICS meet  • India, IMF discuss growth outlook, global trade shifts and macroeconomic cooperation  • Exporters can now apply for certificates of origin directly from their business software: Govt 
Last updated: 01 Feb, 2017  

cadila.thumb.jpg Cadila Healthcare net profit declines 34.6 pc in Q3

cadila.jpg
   Top Stories
» BRICS playing bigger role in new world economic order
» Sensex, Nifty open lower as IPO rush, Middle East tensions weigh on sentiment
» Sensex, Nifty post notable gains in early trade led by IT stocks
» Govt notifies ‘One Nation, One Time’ rules to develop modern digital, critical infra
» DGFT automates issuance of Free Sale and Commerce Certificates for exporters
SME Times News Bureau | 01 Feb, 2017
Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 percent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company's consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 percent from the previous close.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹96.5
₹94.8
UK Pound
₹132.25
₹128.15
Euro
₹113.6
₹109.8
Japanese Yen ₹61.3 ₹59.45
As on 03 Sep, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter